1. Volume 74, Pages S88-S93 (December 2008)
Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients 
Ana M. Ramos, Marta Albalate, Silvia Vázquez, Carlos Caramelo, Jesús Egido, Alberto Ortiz 
Kidney International 
Volume 74, Pages S88-S93 (December 2008)
DOI: /ki
Copyright © 2008 International Society of Nephrology Terms and Conditions

2. Figure 1
Serum calcium (a) decreases whereas serum phosphate (b) and PTH (c) levels increase with progression of CKD stage (mean, s.d.). Broken horizontal lines indicate the range recommended by Spanish Society of Nephrology (SEN) CKD-MBD guidelines.6
Kidney International  , S88-S93DOI: ( /ki )
Copyright © 2008 International Society of Nephrology Terms and Conditions

3. Figure 2
Percentage of patients outside the guidelines, at baseline and at 1 year of follow-up. Ca: Calcium >9.5mg per 100ml; P: phosphate >4.6mg per 100ml for CKD 3, 4 and >5mg per 100ml for CKD 5; iPTH >65pg/ml for CKD 3, >110pg/ml for CKD 4 and >300pg/ml for CKD 5; LDL: LDL cholesterol >100mg per 100ml for primary prevention and >70mg per 100ml for secondary prevention; uric acid >7mg per 100ml. 22 CKD 3, 38 CKD 4, and 9 CKD 5 patients were analyzed.
Kidney International  , S88-S93DOI: ( /ki )
Copyright © 2008 International Society of Nephrology Terms and Conditions